A single species of clostridium Subcluster XIVa decreased in ulcerative colitis patients

Inflammatory Bowel Diseases

Volumn 22, Issue 12, 2016, Pages 2802-2810

  Takeshita, Kozue ^a   Mizuno, Shinta ^a   Mikami, Yohei ^a   Sujino, Tomohisa ^a   Saigusa, Keiichiro ^a   Matsuoka, Katsuyoshi ^a   Naganuma, Makoto ^a   Sato, Tadashi ^b   Takada, Toshihiko ^b   Tsuji, Hirokazu ^b   Kushiro, Akira ^b   Nomoto, Koji ^b   Kanai, Takanori ^a  

^a KEIO UNIVERSITY   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Clostridium subcluster XIVa; colitis; dysbiosis; Fusicatenibacter saccharivorans; ulcerative colitis

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 10; MESALAZINE; PROBIOTIC AGENT; RNA 16S; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIUM ISOLATION; CELL STIMULATION; CLOSTRIDIUM; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FUSICATENIBACTER SACCHARIVORANS; GENE SEQUENCE; HUMAN; IMMUNOMODULATION; LAMINA PROPRIA; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULCERATIVE COLITIS; YOUNG ADULT; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; DISEASE EXACERBATION; FECES; GENETICS; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA; MICROBIOLOGY; MIDDLE AGED; MUCOSA; PHYSIOLOGY; SPECIES DIFFERENCE;

ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CLOSTRIDIUM; COLITIS, ULCERATIVE; DISEASE PROGRESSION; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MUCOUS MEMBRANE; RNA, RIBOSOMAL, 16S; SPECIES SPECIFICITY; YOUNG ADULT;

EID: 84994614224     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000972     Document Type: Article

References (36)

1. Ron S, Shai F, Ron M. Are we really vastly outnumbered bacterial ratio. Cell. 2016; 164: 337-340
2. Blaser M, Bork P, Fraser C, et al. The microbiome explored: recent insights and future challenges. Nat Rev Microbiol. 2013; 11: 213-217
3. Clemente JC, Ursell LK, Parfrey LW, et al. The impact of the gut microbiota on human health: an integrative view. Cell. 2012; 148: 1258-1270
4. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005; 308: 1635-1638
5. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504: 446-450
6. Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009; 461: 1282-1286
7. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010; 28: 573-621
8. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417-429
9. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006; 3: 390-407
10. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998; 66: 5224-5231
11. Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013; 500: 232-236
12. Hayashi A, Sato T, Kamada N, et al. A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe. 2013; 13: 711-722
13. Kashiwagi I, Morita R, Schichita T, et al. Smad2 and Smad3 inversely regulate TGF-b autoinduction in Clostridium butyricum-activated dendritic cells. Immunity. 2015; 43: 65-79
14. Kurakawa T, Ogata K, Matsuda K, et al. Diversity of intestinal Clostridium coccoides group in the Japanese population, as demonstrated by reverse transcription-quantitative PCR. PLoS One. 2015; 10: e0126226
15. Matsuki T, Watanabe K, Fujimoto J, et al. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004; 70: 7220-7228
16. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010; 464: 59-65
17. Frank DN, St. Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104: 13780-13785
18. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008; 453: 620-625
19. Takaishi H, Matsuki T, Nakazawa A, et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol. 2008; 298: 463-472
20. Takada T, Kurakawa T, Tsuji H, et al. Fusicatenibacter saccharivorans gen. nov., sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2013; 63: 3691-3696
21. Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol. 2007; 73: 32-39
22. Matsuda K, Tsuji H, Asahara T, et al. Establishment of an analytical system for the human fecal microbiota, based on reverse transcriptionquantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol. 2009; 75: 1961-1969
23. Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007; 2: 541-546
24. Kennedy RJ, Hoper M, Deodhar K, et al. Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease. Br J Surg. 2000; 87: 1346-1351
25. Zhang HQ, Ding TT, Zhao JS, et al. Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats. World J Gastroenterol. 2009; 15: 1821-1828
26. Olszak T, Neves JF, Dowds CM, et al. Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature. 2014; 509: 497-502
27. Kanai T, Watanabe M, Okazawa A, et al. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology. 2001; 121: 875-888
28. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013; 145: 158-165. e152
29. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011; 140: 1785-1794
30. Zhu S, Bing Y, Wang X, et al. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice. PLoS One. 2014; 9: e100167
31. Rosen MJ, Chaturvedi R, Washington MK, et al. STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines. J Immunol. 2013; 190: 1849-1858
32. Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012; 336: 489-493
33. Heller F, Fuss IJ, Nieuwenhuis EE, et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 2002; 17: 629-638
34. Boirivant M, Fuss IJ, Chu A, et al. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med. 1998; 188: 1929-1939
35. Matsuoka K, Mizuno S, Hayashi A, et al. Fecal microbiota transplantation for gastrointestinal diseases. Keio J Med. 2014; 63: 69-74
36. Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015; 149: 102-109. e106